HCC
Conditions
Interventions
Sponsors
Dazhou Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 75 years old, regardless of gender; 2. Patients pathologically diagnosed with hepatocellular carcinoma (HCC), or HCC patients meeting the non-invasive diagnostic criteria of the AASLD/EASL guidelines; 3. Having complete baseline clinical phenotype data and laboratory test results; 4. Having high-quality abdominal enhanced CT or MRI imaging data (slice thickness <=5 mm) within 1 month before treatment, which can be used for extracting radiomics features; 5. Agreeing to provide tissue and/or blood samples for multi-omics (such as metagenomics, transcriptomics, etc.) sequencing analysis; 6. The subject or their legal representative has signed a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with severe diseases in other systems (such as severe cardiorespiratory failure) or a previous history of other malignancies; 2. Clinical data and medical images are severely lacking or have obvious artifacts, making omics analysis impossible; 3. Poor compliance, with an expected inability to cooperate in completing the web-based patient follow-up system and long-term follow-up; 4. Patients in whom the researcher believes there are other situations not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Recurrence-Free Survival, RFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-index;Area Under the ROC Curve;Calibration curve;DCA; | — |
Countries
China
Contacts
Public ContactFanxin Zeng
Dazhou Central Hospital
Outcome results
None listed